Bensler LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bensler LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 2,522 shares of the medical equipment provider’s stock, valued at approximately $1,316,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,265 shares of company stock worth $21,964,281 in the last ninety days. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on ISRG shares. Robert W. Baird raised their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $566.47 on Tuesday. The stock has a market cap of $201.76 billion, a P/E ratio of 91.43, a P/E/G ratio of 5.19 and a beta of 1.39. The stock’s 50 day simple moving average is $547.16 and its 200-day simple moving average is $505.21. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.